Literature DB >> 19551468

NAP protects against cyanide-related microtubule destruction.

Ilona Zemlyak1, Robert Sapolsky, Illana Gozes.   

Abstract

The peptide NAP (NAPVSIPQ) was shown to protect neurons against a wide variety of insults. Particularly, NAP was shown to be neuroprotective in vitro against cyanide in hippocampal cultures and against oxygen-glucose deprivation in hippocampal and cortical neuronal cultures. Cyanide causes energy depletion in the cell and destroys the cytoskeleton, and NAP has been shown before to protect the microtubule cytoskeleton. The current study explored the effect of NAP on cyanide-induced microtubule destruction in cerebral cortical cultures. Sodium cyanide (6.8 mM) reduced the number of neurons containing intact microtubules as identified by bIII-tubulin immunostaining. When sodium cyanide was added together with NAP (10(-14)-10(-12) M), complete protection was observed. Although the primary site of action of cyanide is considered to be the mitochondria, the current results involve microtubule destruction by cyanide toxicity that is completely reversed by NAP treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19551468     DOI: 10.1007/s00702-009-0252-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  52 in total

1.  Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex.

Authors:  S Brooke; R Chan; S Howard; R Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

2.  NAP enhances neurodevelopment of newborn apolipoprotein E-deficient mice subjected to hypoxia.

Authors:  Michael Rotstein; Haim Bassan; Naam Kariv; Zipora Speiser; Shaul Harel; Illana Gozes
Journal:  J Pharmacol Exp Ther       Date:  2006-07-05       Impact factor: 4.030

3.  Tubulin microheterogeneity increases with rat brain maturation.

Authors:  I Gozes; U Z Littauer
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

4.  Multiple tubulin forms are expressed by a single neurone.

Authors:  I Gozes; K J Sweadner
Journal:  Nature       Date:  1981-12-03       Impact factor: 49.962

Review 5.  NAP: research and development of a peptide derived from activity-dependent neuroprotective protein (ADNP).

Authors:  Illana Gozes; Bruce H Morimoto; Jacqueline Tiong; Anthony Fox; Karole Sutherland; David Dangoor; Miriam Holser-Cochav; Karin Vered; Paul Newton; Paul S Aisen; Yasuji Matsuoka; Christopher H van Dyck; Leon Thal
Journal:  CNS Drug Rev       Date:  2005

6.  Cyanide sensitive and insensitive bioenergetics in a clonal neuroblastoma x glioma hybrid cell line.

Authors:  P Ray; F L Monroe; J D Berman; J Fiedler
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

7.  Mitochondrial function is required for hydrogen peroxide-induced growth factor receptor transactivation and downstream signaling.

Authors:  Kai Chen; Shane R Thomas; Adam Albano; Michael P Murphy; John F Keaney
Journal:  J Biol Chem       Date:  2004-06-04       Impact factor: 5.157

8.  A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease.

Authors:  Yasuji Matsuoka; Yan Jouroukhin; Audrey J Gray; Li Ma; Chiho Hirata-Fukae; Hui-Fang Li; Li Feng; Laurent Lecanu; Benjamin R Walker; Emmanuel Planel; Ottavio Arancio; Illana Gozes; Paul S Aisen
Journal:  J Pharmacol Exp Ther       Date:  2008-01-16       Impact factor: 4.030

9.  NAP protects hippocampal neurons against multiple toxins.

Authors:  Ilona Zemlyak; Nathan Manley; Robert Sapolsky; Illana Gozes
Journal:  Peptides       Date:  2007-08-11       Impact factor: 3.750

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  7 in total

1.  Strategies to defeat ketamine-induced neonatal brain injury.

Authors:  C P Turner; S Gutierrez; C Liu; L Miller; J Chou; B Finucane; A Carnes; J Kim; E Shing; T Haddad; A Phillips
Journal:  Neuroscience       Date:  2012-02-23       Impact factor: 3.590

Review 2.  Mitochondrial dysfunction as a therapeutic target in progressive supranuclear palsy.

Authors:  Vincent Ries; Wolfgang H Oertel; Günter U Höglinger
Journal:  J Mol Neurosci       Date:  2011-07-27       Impact factor: 3.444

Review 3.  D-NAP prophylactic treatment in the SOD mutant mouse model of amyotrophic lateral sclerosis: review of discovery and treatment of tauopathy.

Authors:  Yan Jouroukhin; Regina Ostritsky; Illana Gozes
Journal:  J Mol Neurosci       Date:  2012-11       Impact factor: 3.444

4.  The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities.

Authors:  Saar Oz; Yanina Ivashko-Pachima; Illana Gozes
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

5.  Carbamoylation correlates of cyanate neuropathy and cyanide poisoning: relevance to the biomarkers of cassava cyanogenesis and motor system toxicity.

Authors:  Samuel Kimani; Victor Moterroso; Mike Lasarev; Sinei Kipruto; Fred Bukachi; Charles Maitai; Larry David; Desire Tshala-Katumbay
Journal:  Springerplus       Date:  2013-12-02

Review 6.  ADNP: in search for molecular mechanisms and innovative therapeutic strategies for frontotemporal degeneration.

Authors:  Illana Gozes; Yanina Ivashko-Pachima
Journal:  Front Aging Neurosci       Date:  2015-10-29       Impact factor: 5.750

Review 7.  The two faces of cyanide: an environmental toxin and a potential novel mammalian gasotransmitter.

Authors:  Karim Zuhra; Csaba Szabo
Journal:  FEBS J       Date:  2021-08-05       Impact factor: 5.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.